![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Rado Jeffrey Janicak Philip G
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.11, Iss.12, 2010-08, pp. : 2087-2093
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Iloperidone set to take on schizophrenia
Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lavedan Christian Volpi Simona Polymeropoulos Mihael H Wolfgang Curt D
Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By > Yu Weiping Detraux Johan Sweers Kim > Correll Christoph U.
CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Haloperidol/iloperidone: Angioedema: case report
Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. :